These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1501629)

  • 1. The HIV wasting syndrome.
    Bélec L; Mhiri C; DiCostanzo B; Gherardi R
    Muscle Nerve; 1992 Jul; 15(7):856-7. PubMed ID: 1501629
    [No Abstract]   [Full Text] [Related]  

  • 2. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR; Shebert R; Gregorios JB
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract]   [Full Text] [Related]  

  • 3. Zidovudine and other drugs against HIV.
    Drug Ther Bull; 1988 Dec; 26(26):101-4. PubMed ID: 3065024
    [No Abstract]   [Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Muscular involvement in the course of AIDS. Anatomo-clinical study of 17 cases].
    Butori C; Desnuelle C; Hofman P; Paquis V; Durant J; Carles M; Pesce A; Michiels JF
    Ann Pathol; 1995; 15(6):424-30. PubMed ID: 8720838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for use of zidovudine in adult and pediatric inpatients and outpatients.
    Goodwin SD; Shipp KW
    Clin Pharm; 1992 Jan; 11(1):63-8. PubMed ID: 1730181
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant hepatic failure in an AIDS patient: possible zidovudine-induced hepatotoxicity.
    Shintaku M; Nasu K; Shimizu T
    Am J Gastroenterol; 1993 Mar; 88(3):464-6. PubMed ID: 8438867
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute demyelinating polyneuropathy in HIV infection treated with zidovudine].
    Santos Gil I; García Polo I; Vivancos Mora J; Noguerado Asensio A
    Rev Clin Esp; 1989 Dec; 185(9):479-80. PubMed ID: 2623285
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ungual blue striae, HIV and zidovudine, what is their etiology?].
    Valencia ME; Pintado V; Lavilla P; Gil Aguado A
    Rev Clin Esp; 1989; 185(3):167-8. PubMed ID: 2623231
    [No Abstract]   [Full Text] [Related]  

  • 10. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
    Corzo JE; Leal M
    Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546
    [No Abstract]   [Full Text] [Related]  

  • 11. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(34):591, 597-600. PubMed ID: 1870560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for HIV-1-related nephritis with zidovudine.
    Harrer T; Hunzelmann N; Stoll R; Baur A; Kalden JR
    AIDS; 1990 Aug; 4(8):815-7. PubMed ID: 2261137
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of myopathy in a placebo-controlled zidovudine trial.
    Simpson DM; Slasor P; Dafni U; Berger J; Fischl MA; Hall C
    Muscle Nerve; 1997 Mar; 20(3):382-5. PubMed ID: 9052824
    [No Abstract]   [Full Text] [Related]  

  • 15. Zidovudine and human immunodeficiency virus-associated peripheral neuropathies: low intake in patients with mononeuropathy multiplex and no evidence for neurotoxicity.
    Lefaucheur JP; Authier FJ; Verroust J; Gherardi RK
    Muscle Nerve; 1997 Jan; 20(1):106-9. PubMed ID: 8995592
    [No Abstract]   [Full Text] [Related]  

  • 16. Transient myasthenia gravis during HIV infection.
    Authier FJ; De Grissac N; Degos JD; Gherardi RK
    Muscle Nerve; 1995 Aug; 18(8):914-6. PubMed ID: 7630356
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematologic toxicity of zidovudine in HIV-infected patients.
    Brogan KL; Zell SC
    Am Fam Physician; 1990 May; 41(5):1521-8. PubMed ID: 1692180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with zidovudine of thrombopenia associated with human immunodeficiency virus infection. Changes in erythropoiesis].
    Aguilar Ligorit E; Benet Monforte I; Pascual López A; García-Conde Bru J
    Med Clin (Barc); 1989 Nov; 93(14):556-7. PubMed ID: 2622255
    [No Abstract]   [Full Text] [Related]  

  • 20. More on zidovudine and HIV-related thrombocytopenia.
    Wallis RS
    N Engl J Med; 1989 Aug; 321(9):614-5. PubMed ID: 2761604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.